COVID-19-related drugs are in short supply in the U.S., according to a recent report from the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. Supplies are scarce for nearly three-quarters (72.5% or 29 of 40) of COVID-19 drugs, according to the CIDRAP report, which cites data from the American Society…